4//SEC Filing
WEISS MICHAEL S 4
Accession 0001104659-24-062667
CIK 0001651407other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:35 PM ET
Size
7.3 KB
Accession
0001104659-24-062667
Insider Transaction Report
Form 4
WEISS MICHAEL S
Director
Transactions
- Award
COMMON STOCK
2024-05-14+32,051→ 62,174 total(indirect: See Note 3) - Award
COMMON STOCK
2024-05-14+50,000→ 112,174 total(indirect: See Note 3)
Footnotes (4)
- [F1]The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Weiss's continued service on the board on such date.
- [F2]Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board.
- [F3]The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member.
- [F4]The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Weiss's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001038977
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:35 PM ET
- Size
- 7.3 KB